Guangzhou Innogen Pharmaceutical Group Co., Ltd. engages in the production and distribution of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 105 full-time employees. The company went IPO on 2025-08-15. The firm is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The firm is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The firm principally conducts its businesses in the domestic market.
02591.HK stock price ended at $27.34 on Jueves, after dropping 1.01%
On the latest trading day Feb 12, 2026, the stock price of 02591.HK fell by 1.01%, dropping from $27.62 to $27.34. During the session, the stock saw a volatility of 3.01%, with prices oscillating between a daily low of $27.26 and a high of $28.08. On the latest trading day, the trading volume for 02591.HK decreased by 23.4K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 223.6K shares were traded, with a market value of approximately $11.4B.
Señales Técnicas de 02591.HK
Resumen de Señales Técnicas
Señales de compra 1
Señales Neutras 1
Señales de venta 5
Strong Sell
Sell
Neutral
Buy
Strong Buy
02591.HK actualmente presenta 1 señales de compra y 5 señales de venta. La acción ha estado en una tendencia bajista desde 12:00 AM, con un cambio total en el precio de -1.3% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Strong Sell para el mediano plazo.
Señales alcistas/bajistas para 02591.HK
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para 02591.HK. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.